Clinical Trials Directory

Trials / Completed

CompletedNCT03302429

Evaluation of Platelet Rich Fibrin / Biphasic Calcium Phosphate Effect Versus Autogenous Bone Graft on Reconstruction of Alveolar Cleft

Evaluation of Platelet-rich Fibrin / Biphasic Calcium Phosphate Effect Versus Autogenous Bone Graft on Reconstruction of Alveolar Cleft Defect in the Maxillary Arch: Randomized Controlled Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
8 Years
Healthy volunteers
Not accepted

Summary

P- Maxillary alveolar cleft defects I- Platelet-rich fibrin (PRF) combined with biphasic calcium phosphate (BCP) C- Autogenous bone graft O- Outcome measure : bone height, bone volume, hospital stay, operation duration T- 6 months S- Randomized controlled clinical trial this study aimed to answer a clinical question whether the use of Platelet-rich Fibrin (PRF) combined with Biphasic Calcium Phosphate (BCP), can be an alternative to autogenous bone graft in reconstruction of alveolar cleft defect in maxillary arch.

Detailed description

this study aimed to answer a clinical question whether the use of Platelet-rich Fibrin (PRF) combined with Biphasic Calcium Phosphate (BCP), can be an alternative to autogenous bone graft in reconstruction of alveolar cleft defect in maxillary arch

Conditions

Interventions

TypeNameDescription
OTHERPRF/ BCPPlatelet rich fibrin combined with biphasic calcium phosphate(experimental group)
OTHERAutogenous bone graftBone obtained from the same individual who receiving the graft

Timeline

Start date
2017-11-19
Primary completion
2023-01-27
Completion
2023-03-30
First posted
2017-10-05
Last updated
2024-11-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03302429. Inclusion in this directory is not an endorsement.